Opus Point Partners Management, LLC current holdings: USA Other Stocks
Opus Point Partners Management, LLC reported $0.02 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 19 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are SEATTLE GENETICS INC, NEKTAR THERAPEUTICS, QIAGEN NV.
- SEATTLE GENETICS INC: Country of operation —; Class COM; Shares 67,953; Value $3,670,000.
- NEKTAR THERAPEUTICS: Country of operation United States; Class COM; Shares 176,611; Value $3,034,000.
- QIAGEN NV: Country of operation —; Class REG SHS; Shares 110,565; Value $3,034,000.
- ALEXION PHARMACEUTICALS INC: Country of operation —; Class COM; Shares 24,571; Value $3,011,000.
Form 13F-HR as filed (SEC CIK 1600175): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
SEATTLE GENETICS INC
CUSIP 812578102 | | COM | 67,953 | $3,670,000 | 2016-09-30 | 2016-11-14 |
|---|
NEKTAR THERAPEUTICS
CUSIP 640268108 | United States | COM | 176,611 | $3,034,000 | 2016-09-30 | 2016-11-14 |
|---|
QIAGEN NV
CUSIP N72482107 | | REG SHS | 110,565 | $3,034,000 | 2016-09-30 | 2016-11-14 |
|---|
ALEXION PHARMACEUTICALS INC
CUSIP 015351109 | | COM | 24,571 | $3,011,000 | 2016-09-30 | 2016-11-14 |
|---|
CELGENE CORP
CUSIP 151020104 | | COM | 26,859 | $2,808,000 | 2016-09-30 | 2016-11-14 |
|---|
MEDICINES CO
CUSIP 584688105 | | COM | 28,000 | $1,057,000 | 2016-09-30 | 2016-11-14 |
|---|
PARATEK PHARMACEUTICALS INC
CUSIP 699374302 | United States | COM | 80,000 | $1,041,000 | 2016-09-30 | 2016-11-14 |
|---|
ADAMAS PHARMACEUTICALS INC
CUSIP 00548A106 | | COM | 60,000 | $985,000 | 2016-09-30 | 2016-11-14 |
|---|
CONTRAFECT CORP
CUSIP 212326102 | | COM | 300,000 | $744,000 | 2016-09-30 | 2016-11-14 |
|---|
PORTOLA PHARMACEUTICALS INC
CUSIP 737010108 | | COM | 25,000 | $568,000 | 2016-09-30 | 2016-11-14 |
|---|
CEPHEID
CUSIP 15670R107 | | COM | 5,985 | $315,000 | 2016-09-30 | 2016-11-14 |
|---|
OPHTHOTECH CORP
CUSIP 683745103 | | COM | 6,746 | $311,000 | 2016-09-30 | 2016-11-14 |
|---|
QUINTILES TRANSNATIO HLDGS I
CUSIP 74876Y101 | | COM | 2,730 | $221,000 | 2016-09-30 | 2016-11-14 |
|---|
INTERCEPT PHARMACEUTICALS IN
CUSIP 45845P108 | United States | COM | 1,306 | $215,000 | 2016-09-30 | 2016-11-14 |
|---|
AXOVANT SCIENCES LTD
CUSIP G0750W104 | | COM | 14,844 | $208,000 | 2016-09-30 | 2016-11-14 |
|---|
JUNO THERAPEUTICS INC
CUSIP 48205A109 | | COM | 6,918 | $208,000 | 2016-09-30 | 2016-11-14 |
|---|
LION BIOTECHNOLOGIES INC
CUSIP 53619R102 | | COM | 23,594 | $194,000 | 2016-09-30 | 2016-11-14 |
|---|
SERES THERAPEUTICS INC
CUSIP 81750R102 | United States | COM | 14,000 | $172,000 | 2016-09-30 | 2016-11-14 |
|---|
NOVAVAX INC
CUSIP 670002104 | | COM | 25,787 | $54,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |